0001636422-26-000051
SEC filingHealth Catalyst, Inc. appointed Steven Nelson as a Class II member of its Board of Directors effective May 1, 2026, expanding the Board to seven directors before reducing it to six following Matthew Kolb’s non-re-election at the 2026 Annual Meeting.
Steven Nelson’s appointment reflects a strategic board refresh aligned with Health Catalyst’s stated leadership transformation, following the earlier naming of Ben Albert as CEO and Justin Spencer as Chairman. His extensive background across payer (Aetna, UnitedHealthcare), value-based provider (ChenMed, Duly Health and Care), and integrated delivery leadership positions provides domain-specific insight directly relevant to Health Catalyst’s core customers—health systems navigating cost, clinical outcomes, and consumer experience pressures. While the filing confirms no material related-party transactions, his compensation is standardized under existing non-employee director arrangements, indicating no special terms. The temporary expansion to seven directors—followed by a reduction to six after Matthew Kolb’s non-re-election—suggests deliberate governance calibration ahead of the 2026 Annual Meeting, reinforcing board continuity and succession planning. Though not a C-suite executive change, this director appointment carries medium materiality due to Nelson’s high-profile operational pedigree and explicit linkage in Exhibit 99.1 to the company’s AI-enabled strategy execution.